线粒体能量代谢在心脏衰竭中的研究进展
Progress in the Study of Mitochondrial Energy Metabolism in Heart Failure
DOI: 10.12677/acm.2024.143923, PDF,   
作者: 谭旭鑫, 但 伶*:重庆医科大学附属第二医院麻醉科,重庆
关键词: 心脏衰竭线粒体能量代谢氧化应激Heart Failure Mitochondrial Energy Metabolism Oxidative Stress
摘要: 心脏衰竭,作为一个全球性的公共健康挑战,与心脏的能量代谢过程紧密相关。在这一过程中,线粒体发挥着核心作用,它不仅是心脏能量供应的主力军,还在维持心脏细胞的生存与功能方面扮演着关键角色。本文细致探讨了线粒体能量代谢的基础知识,涉及线粒体的结构特征、功能重要性以及其在心脏能量供应链中的角色。进一步,我们深入分析了心脏衰竭状态下线粒体能量代谢失调的分子机理,这包括氧化应激引起的线粒体损伤、线粒体动态性的变化,以及线粒体自噬对心脏衰竭的影响。此外,本综述还着重讨论了心脏衰竭治疗中的线粒体靶向策略,包括保护线粒体的方法、促进线粒体功能恢复的药物治疗,以及新兴治疗手段和临床实验的进展。最终,文章指出了未来研究的方向,强调进一步探究线粒体动态与心脏衰竭之间的联系、寻找新的治疗靶点及发展个性化治疗方案的重要性。总的来说,本综述文章为理解心脏衰竭的病理生理机制提供了新视角,并指明了未来治疗研究的方向。
Abstract: Heart failure represents a significant global public health issue, intricately connected to the dynamics of cardiac energy metabolism. Within this critical biological process, mitochondria emerge as central figures, not merely as the main source of energy for the heart but also as key players in ensuring the vitality and functionality of cardiac cells. This article offers a detailed examination of mitochondrial energy metabolism, highlighting the structural attributes of mitochondria, their functional significance, and their indispensable role in the cardiac energy supply network. Additionally, we probe into the molecular intricacies underlying the disruption of mitochondrial energy metabolism in heart failure, spotlighting the adverse effects of oxidative stress-induced mitochondrial damage, alterations in mitochondrial dynamics, and the consequential role of mitochondrial autophagy in heart failure scenarios. Furthermore, this review sheds light on mitochondrial-centric therapeutic strategies for heart failure management, including protective measures for mitochondria, pharmacological interventions aimed at rejuvenating mitochondrial function, and the advancement of novel treatment modalities and clinical trials. Looking ahead, the article underscores the critical need for further investigation into the interplay between mitochondrial dynamics and heart failure, the pursuit of innovative therapeutic targets, and the cultivation of personalized treatment methodologies. In essence, this review lays out a fresh perspective on the pathophysiological underpinnings of heart failure and carves out a roadmap for future therapeutic research endeavors.
文章引用:谭旭鑫, 但伶. 线粒体能量代谢在心脏衰竭中的研究进展[J]. 临床医学进展, 2024, 14(3): 1908-1914. https://doi.org/10.12677/acm.2024.143923

参考文献

[1] Ponikowski, P., Voors, A.A., Anker, S.D., et al. (2016) 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the Special Contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 18, 891-975. [Google Scholar] [CrossRef] [PubMed]
[2] Jessup, M., Abraham, W.T., Casey, D.E., et al. (2009) 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration with the International Society for Heart and Lung Transplantation. Circulation, 119, 1977-2016. [Google Scholar] [CrossRef
[3] Zhou, B. and Tian, R. (2018) Mitochondrial Dysfunction in Pathophysiology of Heart Failure. Journal of Clinical Investigation, 128, 3716-3726. [Google Scholar] [CrossRef
[4] Snipelisky, D., Chaudhry, S.P. and Stewart, G.C. (2019) The Many Faces of Heart Failure. Cardiac Electrophysiology Clinics, 11, 11-20. [Google Scholar] [CrossRef] [PubMed]
[5] Phan, T.T., Abozguia, K., Shivu, G.N., et al.(2009) Heart Failure with Preserved Ejection Fraction Is Characterized by Dynamic Impairment of Active Relaxation and Contraction of the Left Ventricle on Exercise and Associated with Myocardial Energy Deficiency. Journal of the American College of Cardiology, 54, 402-409. [Google Scholar] [CrossRef] [PubMed]
[6] Nunnari, J. and Suomalainen, A. (2012) Mitochondria: In Sickness and in Health. Cell, 148, 1145-1159. [Google Scholar] [CrossRef] [PubMed]
[7] Frey, T.G. and Mannella, C.A. (2000) The Internal Structure of Mitochondria. Trends in Biochemical Sciences, 25, 319-324. [Google Scholar] [CrossRef
[8] Bensinger, R. (1967) Mitochondrial ATP Synthesis. The New England Journal of Medicine, 277, 315. [Google Scholar] [CrossRef
[9] Kolwicz, S.C., Purohit, S. and Tian, R. (2013) Cardiac Metabolism and Its Interactions with Contraction, Growth, and Survival of Cardiomyocytes. Circulation Research, 113, 603-616. [Google Scholar] [CrossRef
[10] Reis, F.H.Z. (2024) Mitochondria and the Heart. European Heart Journal, 1, ehae031. [Google Scholar] [CrossRef
[11] Kartha, C.C. (2011) Energy Metabolism in Cardiomyocyte. In: Kartha C.C., Eds., Cardiomyocytes in Health and Disease, Springer Nature, Beijing, 73-92.
[12] Gallo, G., Rubattu, S. and Volpe, M. (2024) Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities. International Journal of Molecular Sciences, 25, 2667. [Google Scholar] [CrossRef
[13] Doenst, T., Nguyen, T.D. and Abel, E.D. (2013) Cardiac Metabolism in Heart Failure. Circulation Research, 113, 709-724. [Google Scholar] [CrossRef
[14] Nguyen, B.Y., Ruiz‐Velasco, A., Bui, T., et al. (2019) Mitochondrial Function in the Heart: The Insight into Mechanisms and Therapeutic Potentials. British Journal of Pharmacology, 176, 4302-4318. [Google Scholar] [CrossRef] [PubMed]
[15] Lopaschuk, G.D., Karwi, Q.G., Tian, R., et al. (2021) Cardiac Energy Metabolism in Heart Failure. Circulation Research, 128, 1487-1513. [Google Scholar] [CrossRef
[16] Stanley, W.C., Recchia, F.A. and Lopaschuk, G.D. (2005) Myocardial Substrate Metabolism in the Normal and Failing Heart. Physiological Reviews, 85, 1093-1129. [Google Scholar] [CrossRef] [PubMed]
[17] Peoples, J.N., Saraf, A., Ghazal, N., et al. (2019) Mitochondrial Dysfunction and Oxidative Stress in Heart Disease. Experimental & Molecular Medicine, 51, 1-13. [Google Scholar] [CrossRef] [PubMed]
[18] Sanz, R.L., Inserra, F., Menéndez, S.G., et al. (2023) Metabolic Syndrome and Cardiac Remodeling Due to Mitochondrial Oxidative Stress Involving Gliflozins and Sirtuins. Current Hypertension Reports, 25, 91-106. [Google Scholar] [CrossRef] [PubMed]
[19] Lazaropoulos, M.P. and Elrod, J.W. (2022) Mitochondria in Pathological Cardiac Remodeling. Current Opinion in Physiology, 25, Article ID: 100489. [Google Scholar] [CrossRef] [PubMed]
[20] Ritterhoff, J. and Tian, R. (2023) Metabolic Mechanisms in Physiological and Pathological Cardiac Hypertrophy: New Paradigms and Challenges. Nature Reviews Cardiology, 20, 812-829. [Google Scholar] [CrossRef] [PubMed]
[21] Tsutsui, H., Kinugawa, S. and Matsushima, S. (2011) Oxidative Stress and Heart Failure. American Journal of Physiology-Heart and Circulatory Physiology, 301, H2181-2190. [Google Scholar] [CrossRef] [PubMed]
[22] Bhatti, J.S., Bhatti, G.K. and Reddy, P.H. (2017) Mitochondrial Dysfunction and Oxidative Stress in Metabolic Disorders—A Step towards Mitochondria Based Therapeutic Strategies. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1863, 1066-1077. [Google Scholar] [CrossRef] [PubMed]
[23] Tilokani, L., Nagashima, S., Paupe, V., et al. (2018) Mitochondrial Dynamics: Overview of Molecular Mechanisms. Essays in Biochemistry, 62, 341-360. [Google Scholar] [CrossRef
[24] Ren, L., Chen, X., Chen, X., et al. (2020) Mitochondrial Dynamics: Fission and Fusion in Fate Determination of Mesenchymal Stem Cells. Frontiers in Cell and Developmental Biology, 8, Article ID: 580070. [Google Scholar] [CrossRef] [PubMed]
[25] Menezes, T.N., Ramalho, L.S., Bechara, L.R.G., et al. (2020) Targeting Mitochondrial Fission-Fusion Imbalance in Heart Failure. Current Tissue Microenvironment Reports, 1, 239-247. [Google Scholar] [CrossRef
[26] Liu, X., Guo, C. and Zhang, Q. (2023) Novel Insights into the Involvement of Mitochondrial Fission/Fusion in Heart Failure: From Molecular Mechanisms to Targeted Therapies. Cell Stress and Chaperones, 28, 133-144. [Google Scholar] [CrossRef] [PubMed]
[27] Liu, Y., Wang, Y., Bi, Y., et al. (2023) Emerging Role of Mitophagy in Heart Failure: From Molecular Mechanism to Targeted Therapy. Cell Cycle, 22, 906-918. [Google Scholar] [CrossRef] [PubMed]
[28] Yang, Y., Li, T., Li, Z., et al. (2020) Role of Mitophagy in Cardiovascular Disease. Aging and Disease, 11, 419-437. [Google Scholar] [CrossRef
[29] Liu, M., Lv, J., Pan, Z., et al. (2022) Mitochondrial Dysfunction in Heart Failure and Its Therapeutic Implications. Frontiers in Cardiovascular Medicine, 9, Article ID: 945142. [Google Scholar] [CrossRef] [PubMed]
[30] Jiang, Q., Yin, J., Chen, J., et al. (2020) Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment. Oxidative Medicine and Cellular Longevity, 2020, Article ID: 8837893. [Google Scholar] [CrossRef] [PubMed]
[31] Marín-García, J., Akhmedov, A.T. and Moe, G.W. (2013) Mitochondria in Heart Failure: The Emerging Role of Mitochondrial Dynamics. Heart Failure Reviews, 18, 439-456. [Google Scholar] [CrossRef] [PubMed]
[32] Wu, D., Dasgupta, A., Chen, K.H., et al. (2020) Identification of Novel Dynamin-Related Protein 1 (Drp1) GTPase Inhibitors: Therapeutic Potential of Drpitor1 and Drpitor1a in Cancer and Cardiac Ischemia-Reperfusion Injury. The FASEB Journal, 34, 147-1464. [Google Scholar] [CrossRef
[33] Ishikita, A., Matoba, T., Ikeda, G., et al. (2016) Nanoparticle-Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart from Ischemia-Reperfusion Injury through Inhibition of Mitochondria Outer Membrane Permeabilization: A New Therapeutic Modality for Acute Myocardial Infarction. Journal of the American Heart Association, 5, e003872. [Google Scholar] [CrossRef
[34] Disatnik, M.H., Ferreira, J.C.B., Campos, J.C., et al. (2013) Acute Inhibition of Excessive Mitochondrial Fission after Myocardial Infarction Prevents Long-Term Cardiac Dysfunction. Journal of the American Heart Association, 2, e000461. [Google Scholar] [CrossRef
[35] Shu, H., Peng, Y., Hang, W., et al. (2021) Trimetazidine in Heart Failure. Frontiers in Pharmacology, 11, Article ID: 569132. [Google Scholar] [CrossRef] [PubMed]
[36] Lewis, J.F., Dacosta, M., Wargowich, T., et al. (1998) Effects of Dichloroacetate in Patients with Congestive Heart Failure. Clinical Cardiology, 21, 888-892. [Google Scholar] [CrossRef] [PubMed]
[37] Rabanal-Ruiz, Y., Llanos-González, E. and Alcain, F.J. (2021) The Use of Coenzyme Q10 in Cardiovascular Diseases. Antioxidants, 10, Article No. 755. [Google Scholar] [CrossRef] [PubMed]
[38] Hoang, D.M., Pham, P.T., Bach, T.Q., et al. (2022) Stem Cell-Based Therapy for Human Diseases. Signal Transduction and Targeted Therapy, 7, 272. [Google Scholar] [CrossRef] [PubMed]
[39] Kieserman, J.M., Myers, V.D., Dubey, P., et al. (2019) Current Landscape of Heart Failure Gene Therapy. Journal of the American Heart Association, 8, e012239. [Google Scholar] [CrossRef